Vulinacimab, CAS 2250342-36-8

Product Description: Vulinacimab (HLX-06) is an anti-VEGFR-2 monoclonal antibody (mAb). Vulinacimab can be used in the research of cancers. VEGFR-2, overexpressed in certain tumors, is critical in angiogenesis and the proliferation, survival, migration and differentiation of endothelial cells[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Peach CJ, et al Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2. Int J Mol Sci. 2018 Apr 23;19(4):1264.

CAS Number: 2250342-36-8

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: VEGFR

• Artikelnummer: MEXHY-P99516-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99516-1
• Verpackungseinheit: 1mg
• Mengeneinheit: STK
• Konjugat: Unconjugated